Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / KDMN - Keros Therapeutics appoints Simon Cooper as CMO


KDMN - Keros Therapeutics appoints Simon Cooper as CMO

Keros Therapeutics (KROS +3.8%) announces the appointment of Simon Cooper, M.B.B.S, as Keros' Chief Medical Officer, or CMO, effective as of August 2, 2021. Dr. Cooper most recently served as the Senior Vice President, Chief Medical Officer of Kadmon (NASDAQ:KDMN). Dr. Cooper is succeeding Claudia Ordonez, M.D., who will be pursuing other opportunities. Dr. Ordonez will provide consulting services to Keros until September 15, 2021.

For further details see:

Keros Therapeutics appoints Simon Cooper as CMO
Stock Information

Company Name: Kadmon Holdings Inc.
Stock Symbol: KDMN
Market: NASDAQ
Website: kadmon.com

Menu

KDMN KDMN Quote KDMN Short KDMN News KDMN Articles KDMN Message Board
Get KDMN Alerts

News, Short Squeeze, Breakout and More Instantly...